Caribou Biosciences, Inc. Earnings Per Share, Basic and Diluted
Caribou Biosciences, Inc. (CRBU) reported Earnings Per Share, Basic and Diluted of -$0.32 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-09
- Caribou Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.32.
- Caribou Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.31.
- Caribou Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.46.
- Caribou Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$1.39.
- Caribou Biosciences, Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.11.
- Caribou Biosciences, Inc. earnings per share, basic and diluted for fiscal 2020 was -$4.01.
- Caribou Biosciences, Inc. earnings per share, basic and diluted for fiscal 2019 was -$2.80.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.32 10-Q · filed 2022-05-09 | -$0.62 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.05 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.65 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2021-12-31 | -$0.31 10-K · filed 2022-03-21 | -$0.74 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.39 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$2.11 10-K · filed 2022-03-21 |
| 2021-09-30 | -$0.46 10-K · filed 2022-03-21 | -$1.26 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$2.20 10-Q · filed 2021-11-09 | -$3.39 derived: net income ÷ weighted average shares · filed 2022-11-08 |
| 2021-06-30 | -$1.39 10-K · filed 2022-03-21 | -$2.78 10-Q · filed 2021-09-02 | -$4.43 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$5.41 derived: net income ÷ weighted average shares · filed 2022-11-08 |
| 2021-03-31 | -$1.39 10-Q · filed 2022-05-09 | -$3.05 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$4.01 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$4.27 derived: net income ÷ weighted average shares · filed 2022-11-08 |
| 2020-12-31 | -$1.68 10-K · filed 2022-03-21 | -$2.61 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$2.85 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$4.01 10-K · filed 2022-03-21 |
| 2020-09-30 | -$0.93 10-K · filed 2022-03-21 | -$1.15 derived: net income ÷ weighted average shares · filed 2022-03-21 | -$2.31 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$0.22 10-K · filed 2022-03-21 | -$1.38 10-Q · filed 2021-09-02 | ||
| 2020-03-31 | -$1.16 10-K · filed 2022-03-21 | |||
| 2019-12-31 | -$2.80 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |